Mesenchymal-endothelial transition contributes to cardiac neovascularization

Nature

Volumn 514, Issue 7524, 2014, Pages 585-590

  Ubil, Eric ^a   Duan, Jinzhu ^b,c   Pillai, Indulekha C L ^b,c   Rosa Garrido, Manuel ^b   Wu, Yong ^b   Bargiacchi, Francesca ^a   Lu, Yan ^b,c   Stanbouly, Seta ^b,c   Huang, Jie ^b,c   Rojas, Mauricio ^a   Vondriska, Thomas M ^b,c   Stefani, Enrico ^b   Deb, Arjun ^b,c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

BIOLOGICAL CHARACTERISTICS; FUNCTIONAL ROLE; GERM CELL; PHENOTYPE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; HEART FUNCTION; HEART INJURY; ISCHEMIA; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PHENOTYPE; ANGIOGENESIS; ANIMAL; CELL TRANSDIFFERENTIATION; CORONARY BLOOD VESSEL; CYTOLOGY; FEMALE; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEART MUSCLE ISCHEMIA; IN VITRO STUDY; MALE; MESODERM; METABOLISM; PATHOLOGY;

ANIMALS; CELL TRANSDIFFERENTIATION; CORONARY VESSELS; ENDOTHELIAL CELLS; FEMALE; FIBROBLASTS; IN VITRO TECHNIQUES; MALE; MESODERM; MICE; MYOCARDIAL ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84908403146     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature13839     Document Type: Article

References (40)

1. Christia, P. et al. Systematic characterization of myocardial inflammation, repair, and remodeling in a mouse model of reperfused myocardial infarction. J. Histochem. Cytochem. 61, 555-570 (2013).
2. Cohn, J. N., Ferrari, R. & Sharpe, N. Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J. Am. Coll. Cardiol. 35, 569-582 (2000).
3. Kocher, A. A. et al. Neovascularization of ischemic myocardium by human bonemarrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nature Med. 7, 430-436 (2001).
4. Souders, C. A., Bowers, S. L. & Baudino, T. A. Cardiac fibroblast: the renaissance cell. Circ. Res. 105, 1164-1176 (2009).
5. Zeisberg, E. M. et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nature Med. 13, 952-961 (2007).
6. Chintalgattu, V., Nair, D. M. & Katwa, L. C. Cardiacmyofibroblasts: a novel source of vascular endothelial growth factor (VEGF) and its receptors Flt-1 and KDR. J. Mol. Cell. Cardiol. 35, 277-286 (2003).
7. Zhao, L. & Eghbali-Webb, M. Release of pro- and anti-angiogenic factors by human cardiac fibroblasts: effects on DNA synthesis and protection under hypoxia in human endothelial cells. Biochim. Biophys. Acta 1538, 273-282 (2001).
8. Qian, L. et al. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 485, 593-598 (2012).
9. Song, K. et al. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 485, 599-604 (2012).
10. Duan, J. et al. Wnt1/β-catenin injury response activates the epicardium and cardiac fibroblasts to promote cardiac repair. EMBO J. 31, 429-442 (2012).
11. Zheng, B., Zhang, Z., Black, C. M., de Crombrugghe, B. & Denton, C. Liganddependent genetic recombination in fibroblasts: a potentially powerful technique for investigating gene function in fibrosis. Am. J. Pathol. 160, 1609-1617 (2002).
12. Liu, S., Thompson, K. & Leask, A. CCN2 expression by fibroblasts is not required for cutaneous tissue repair. Wound Repair Regen. 22, 119-124 (2014).
13. Madisen, L. et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nature Neurosci. 13, 133-140 (2010).
14. Dejana, E. Endothelial cell-cell junctions: happy together. Nature Rev. Mol. Cell Biol. 5, 261-270 (2004).
15. Singh, H. et al. Visualization and quantification of cardiac mitochondrial protein clusters with STED microscopy. Mitochondrion 12, 230-236 (2012).
16. Li, Y. et al. Direct labeling and visualization of blood vessels with lipophilic carbocyanine dye DiI. Nature Protocols 3, 1703-1708 (2008).
17. Urbich, C. & Dimmeler, S. Endothelial progenitor cells: characterization and role in vascular biology. Circ. Res. 95, 343-353 (2004).
18. Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C. & Brown, R. A. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nature Rev. Mol. Cell Biol. 3, 349-363 (2002).
19. Weber, K. T., Sun, Y., Bhattacharya, S. K., Ahokas, R. A. & Gerling, I. C. Myofibroblast mediated mechanisms of pathological remodelling of the heart. Nature Rev. Cardiol. 10, 15-26 (2013).
20. Zhou, B. et al. Adult mouse epicardium modulates myocardial injury by secreting paracrine factors. J. Clin. Invest. 121, 1894-1904 (2011).
21. Acharya, A. et al. The bHLH transcription factor Tcf21 is required for lineagespecific EMT of cardiac fibroblast progenitors. Development 139, 2139-2149 (2012).
22. Lin, S. L., Kisseleva, T., Brenner, D. A. & Duffield, J. S. Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am. J. Pathol. 173, 1617-1627 (2008).
23. Melo, L. G. et al. Molecular and cell-based therapies for protection, rescue, and repair of ischemic myocardium: reasons for cautious optimism. Circulation 109, 2386-2393 (2004).
24. Sharpless, N. E. & DePinho, R. A. p53: good cop/bad cop. Cell 110, 9-12 (2002).
25. Hong, H. et al. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 460, 1132-1135 (2009).
26. Chang, C. J. et al. p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nature Cell Biol. 13, 317-323 (2011).
27. Hasan, N. M., Adams, G. E. & Joiner, M. C. Effect of serum starvation on expression and phosphorylation of PKC-alpha and p53 in V79 cells: implications for cell death. Int. J. Cancer 80, 400-405 (1999).
28. Shi, Y. et al. Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin. BMC Cancer 12, 571 (2012).
29. Komarov, P. G. et al. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285, 1733-1737 (1999).
30. Marino, S., Vooijs, M., van Der Gulden, H., Jonkers, J. & Berns, A. Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. Genes Dev. 14, 994-1004 (2000).
31. Issaeva, N. et al. Smallmolecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors. Nature Med. 10, 1321-1328 (2004).
32. Bruhl, T. et al. Homeobox A9 transcriptionally regulates the EphB4 receptor to modulate endothelial cell migration and tube formation. Circ. Res. 94, 743-751 (2004).
33. Boudreau, N., Andrews, C., Srebrow, A., Ravanpay, A. & Cheresh, D. A. Induction of the angiogenic phenotype by Hox D3. J. Cell Biol. 139, 257-264 (1997).
34. + cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J. Clin. Invest. 116, 1865-1877 (2006).
35. Economopoulou, M. et al. Histone H2AX is integral to hypoxia-driven neovascularization. Nature Med. 15, 553-558 (2009).
36. Bishopric, N. H. et al. Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or apHshift and is independent of p53. J. Clin. Invest. 104,239-252 (1999).
37. Bolte, S. & Cordelieres, F. P. A guided tour into subcellular colocalization analysis in light microscopy. J. Microsc. 224, 213-232 (2006).
38. McDonald, J. H. & Dunn, K. W. Statistical tests for measures of colocalization in biological microscopy. J. Microsc. 252, 295-302 (2013).
39. Agocha, A. E. & Eghbali-Webb, M. A simple method for preparation of cultured cardiac fibroblasts from adult human ventricular tissue. Mol. Cell. Biochem. 172, 195-198 (1997).
40. Nagelkerke, J. F., Barto, K. P. & van Berkel, T. J. In vivo and in vitro uptake and degradation of acetylated lowdensity lipoprotein by rat liver endothelial, Kupffer, and parenchymal cells. J. Biol. Chem. 258, 12221-12227 (1983).